Archive: 03/06/2018

Study offers new hope for the fight against genetically determined obesity

Around 2 to 6 percent of all people with obesity develop the condition in early childhood. Obesity-causal mutations in one of the 'appetite genes' gives them a strong genetic predisposition for developing obesity, also called ...

Jun 3, 2018

0

23

ALEX trial results show alectinib further outpacing crizotinib in ALK+ NSCLC

Updated results of the global phase III ALEX trial comparing alectinib with crizotinib as first-line treatment against ALK-positive non-small cell lung cancer show a median progression-free survival (PFS) of 34.8 months in ...

Jun 3, 2018

0

8

Positive results for phase 1 trial of ivosidenib against AML

Early phase clinical trial results presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018 of 258 patients with IDH1+ acute myeloid leukemia (AML) treated with the IDH1 inhibitor ivosidenib ...

Jun 3, 2018

0

6

Updated Phase 1 results of crizotinib against MET-amplified lung cancer

The drug crizotinib has activity against a number of genetic targets relevant to non-small cell lung cancer, already earning FDA-approval against ALK- and ROS1-positive lung cancers. Now updated phase 1 clinical trial results ...

Jun 3, 2018

0

6

Trial shows how PET scans help tailor therapy for esophageal cancer

Survival results for the CALGB 80303 Trial presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018 demonstrate that esophageal cancer patients shown by PET scan to be non-responders to induction ...

Jun 3, 2018

0

4

Targeted cancer treatments far outperform traditional methods

Cancer treatments that attack tumors based on their individual genetic traits—not their location in the body—far outperform traditional methods, extending survival for twice as many patients, a study said Saturday.

Jun 3, 2018

Landmark study finds more breast cancer patients can safely forgo chemotherapy

A 21-gene test performed on tumors could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study published in the New England Journal of Medicine.

Jun 3, 2018

0

5

Many breast cancer patients can skip chemo, big study finds

Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to ...

Jun 3, 2018

0

6

Long-term IMPACT data find improved survival when targeted therapies matched to tumor-specific gene mutations

Matching targeted therapies to tumor-specific gene mutations across tumor types improved progression-free survival (PFS) and overall survival (OS) in patients with advanced disease relative to those receiving non-matched ...

Jun 3, 2018

0

5

Blood test shows potential for early detection of lung cancer

A test that analyzes free-floating DNA in the blood may be able to detect early-stage lung cancer, a preliminary report from the ongoing Circulating Cell-Free Genome Atlas (CCGA) study suggests.

Jun 3, 2018

page 1 from 2

«
»